null

SMILES: N[C@@H](CCN(CCNCCc1ccc(Cl)cc1)C[C@@H]1O[C@@H]([C@@H](O)[C@H]1O)n1cnc2c(N)ncnc12)C(O)=O

InChI Key: InChIKey=WWKSYRSOVZNFOY-HMDXBLRFSA-N

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 5 hits for monomerid = 139690   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Histone-lysine N-methyltransferase EZH2 (Homo sapiens (Human))	BDBM139690 (US8895245, 75) Show SMILES N[C@@H](CCN(CCNCCc1ccc(Cl)cc1)C[C@@H]1O[C@@H]([C@@H](O)[C@H]1O)n1cnc2c(N)ncnc12)C(O)=O |r| Show InChI InChI=1S/C24H33ClN8O5/c25-15-3-1-14(2-4-15)5-7-28-8-10-32(9-6-16(26)24(36)37)11-17-19(34)20(35)23(38-17)33-13-31-18-21(27)29-12-30-22(18)33/h1-4,12-13,16-17,19-20,23,28,34-35H,5-11,26H2,(H,36,37)(H2,27,29,30)/t16-,17-,19-,20-,23-/m0/s1	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	8.95E+3	n/a	n/a	n/a	n/a	7.6	n/a
Epizyme, Inc. US Patent					Assay Description Compound 75 was serially diluted 3 fold in DMSO for 10 points and 1 μL was plated in a 384 well microtiter plate. Positive control (100% inhibit...				US Patent US8895245 (2014) BindingDB Entry DOI: 10.7270/Q2WW7GBK
					More data for this Ligand-Target Pair
Histone-lysine N-methyltransferase EZH2 (Homo sapiens (Human))	BDBM139690 (US8895245, 75) Show SMILES N[C@@H](CCN(CCNCCc1ccc(Cl)cc1)C[C@@H]1O[C@@H]([C@@H](O)[C@H]1O)n1cnc2c(N)ncnc12)C(O)=O |r| Show InChI InChI=1S/C24H33ClN8O5/c25-15-3-1-14(2-4-15)5-7-28-8-10-32(9-6-16(26)24(36)37)11-17-19(34)20(35)23(38-17)33-13-31-18-21(27)29-12-30-22(18)33/h1-4,12-13,16-17,19-20,23,28,34-35H,5-11,26H2,(H,36,37)(H2,27,29,30)/t16-,17-,19-,20-,23-/m0/s1	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	2.50E+3	n/a	n/a	n/a	n/a	7.6	n/a
Epizyme, Inc. US Patent					Assay Description Compound 75 was serially diluted 3 fold in DMSO for 10 points and 1 μL was plated in a 384 well microtiter plate. Positive control (100% inhibit...				US Patent US8895245 (2014) BindingDB Entry DOI: 10.7270/Q2WW7GBK
					More data for this Ligand-Target Pair
Histone-lysine N-methyltransferase EZH2 (Homo sapiens (Human))	BDBM139690 (US8895245, 75) Show SMILES N[C@@H](CCN(CCNCCc1ccc(Cl)cc1)C[C@@H]1O[C@@H]([C@@H](O)[C@H]1O)n1cnc2c(N)ncnc12)C(O)=O |r| Show InChI InChI=1S/C24H33ClN8O5/c25-15-3-1-14(2-4-15)5-7-28-8-10-32(9-6-16(26)24(36)37)11-17-19(34)20(35)23(38-17)33-13-31-18-21(27)29-12-30-22(18)33/h1-4,12-13,16-17,19-20,23,28,34-35H,5-11,26H2,(H,36,37)(H2,27,29,30)/t16-,17-,19-,20-,23-/m0/s1	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	7.56E+3	n/a	n/a	n/a	n/a	7.6	n/a
Epizyme, Inc. US Patent					Assay Description Compound 75 was serially diluted 3 fold in DMSO for 10 points and 1 μL was plated in a 384 well microtiter plate. Positive control (100% inhibit...				US Patent US8895245 (2014) BindingDB Entry DOI: 10.7270/Q2WW7GBK
					More data for this Ligand-Target Pair
Histone-lysine N-methyltransferase EZH2 (Homo sapiens (Human))	BDBM139690 (US8895245, 75) Show SMILES N[C@@H](CCN(CCNCCc1ccc(Cl)cc1)C[C@@H]1O[C@@H]([C@@H](O)[C@H]1O)n1cnc2c(N)ncnc12)C(O)=O |r| Show InChI InChI=1S/C24H33ClN8O5/c25-15-3-1-14(2-4-15)5-7-28-8-10-32(9-6-16(26)24(36)37)11-17-19(34)20(35)23(38-17)33-13-31-18-21(27)29-12-30-22(18)33/h1-4,12-13,16-17,19-20,23,28,34-35H,5-11,26H2,(H,36,37)(H2,27,29,30)/t16-,17-,19-,20-,23-/m0/s1	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	7.18E+3	n/a	n/a	n/a	n/a	7.6	n/a
Epizyme, Inc. US Patent					Assay Description Compound 75 was serially diluted 3 fold in DMSO for 10 points and 1 μL was plated in a 384 well microtiter plate. Positive control (100% inhibit...				US Patent US8895245 (2014) BindingDB Entry DOI: 10.7270/Q2WW7GBK
					More data for this Ligand-Target Pair
Histone-lysine N-methyltransferase EZH2 (Homo sapiens (Human))	BDBM139690 (US8895245, 75) Show SMILES N[C@@H](CCN(CCNCCc1ccc(Cl)cc1)C[C@@H]1O[C@@H]([C@@H](O)[C@H]1O)n1cnc2c(N)ncnc12)C(O)=O |r| Show InChI InChI=1S/C24H33ClN8O5/c25-15-3-1-14(2-4-15)5-7-28-8-10-32(9-6-16(26)24(36)37)11-17-19(34)20(35)23(38-17)33-13-31-18-21(27)29-12-30-22(18)33/h1-4,12-13,16-17,19-20,23,28,34-35H,5-11,26H2,(H,36,37)(H2,27,29,30)/t16-,17-,19-,20-,23-/m0/s1	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	4.10E+3	n/a	n/a	n/a	n/a	7.6	n/a
Epizyme, Inc. US Patent					Assay Description Compound 75 was serially diluted 3 fold in DMSO for 10 points and 1 μL was plated in a 384 well microtiter plate. Positive control (100% inhibit...				US Patent US8895245 (2014) BindingDB Entry DOI: 10.7270/Q2WW7GBK
					More data for this Ligand-Target Pair